SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors aggressively position themselves ahead of the upcoming earnings release and a highly anticipated leadership transition, with active debate regarding the company's AI strategy and potential impact on service revenue. Market participants are closely monitoring options flow and institutional sentiment for signs of a breakout, while the community remains divided over whether current valuations account for long-term growth expectations.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense investor focus as the stock approaches earnings with major community speculation centered on a potential stock split and a blowout performance driven by critical NAND supply shortages. Traders are bracing for high volatility and are closely monitoring how the company's guidance and enterprise SSD demand will impact its massive momentum, with significant debate occurring over whether the current valuation is sustainable or if a pullback is imminent.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc is experiencing intense community focus ahead of its quarterly earnings, with investors debating whether the stock's recent volatility is a setup for a breakout or a signal of further downside. The community is heavily split between bulls highlighting robust advertising growth and AI data tailwinds, and skeptics who are bracing for a potential post-earnings sell-off.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing significant market interest driven by the commencement of R2 production at its Illinois plant and anticipation surrounding upcoming earnings results. The community remains deeply divided, with bulls pointing to the potential for a massive rerate driven by the R2 launch and software revenue, while bears express concern over cash burn, executive compensation, and production scaling hurdles.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is seeing heightened market volatility and intense community discussion as investors weigh the company's strong AI-driven marketing growth against broader SaaS sector pressures and speculative concerns. The stock remains a focal point for traders anticipating catalysts from upcoming earnings and ongoing developments in AI monetization.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently facing significant selling pressure and volatility as investors weigh the company's valuation against concerns over rising AI infrastructure spending and increased competition from custom chips. The community remains deeply divided, with some traders citing structural manipulation by institutions to shake out late longs, while others view the pullback as a buying opportunity in a long-term AI leader.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing intense volatility and downward pressure as market sentiment shifts against the SaaS sector amid fears that AI agents may disrupt established enterprise workflows. While bearish investors are aggressively shorting the stock, citing valuation concerns and potential AI displacement, bullish participants view the current price levels as an oversold buying opportunity, highlighting the company's entrenched market position and high customer switching costs.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as market participants react to ongoing child safety concerns and high volatility surrounding its growth trajectory. While some investors argue that the stock's valuation is depressed and see potential for a rebound, many in the community remain deeply skeptical, expressing concerns about persistent financial losses and the platform's long-term sustainability.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is seeing intense market attention as traders position for earnings volatility and high implied moves, with sentiment driven by strong demand in the storage sector and significant analyst upgrades. Community discussions are split between those betting on continued growth and memory supercycle momentum and others wary of potential overvaluation and earnings disappointment.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors weigh significant ongoing capital expenditure commitments from major tech hyperscalers against broader semiconductor sector volatility. The community remains focused on memory demand cycles and the potential for upward valuation adjustments as institutional sentiment remains heavily bullish.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Down - What's Next?

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Down - What's Next...

Intellia Therapeutics (NASDAQ:NTLA) Price Target Raised to $58.00 at Canaccord Genuity Group

Canaccord Genuity Group increased their target price on Intellia Therapeutics from $48.00 to $58.00 and gave the company a "buy" rating in a report on Tuesday...

NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA

Intellia shares drop 4% despite phase III data meeting all endpoints. The company begins a rolling FDA filing.

Intellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6% After Analyst Upgrade

Intellia Therapeutics (NASDAQ:NTLA) Shares Up 6% After Analyst Upgrade...

Intellia Therapeutics (NASDAQ:NTLA) Price Target Raised to $30.00 at Citizens Jmp

Citizens Jmp lifted their price objective on shares of Intellia Therapeutics from $28.00 to $30.00 and gave the stock a "market outperform" rating in a research note on Tuesday...

<ul class="summary-bullets"><li>The firm has been steadily adding NTLA stock across its ETFs throughout 2026, with repeated purchases in January, February, March, and now April.</li><li>RKLB stock’s sale marks ARK’s second offload this month.</li></ul><p>Cathie Wood’s ARK exchange-traded funds filed two big bets on Monday, loading up on Intellia Therapeutics (NTLA), which is up more than 41% this year, while selling shares of Rocket Lab (RKLB).</p><p>ARK Investment Management bought shares in Intellia Therapeutics, potentially worth more than $3.5 million, through its <a href="https://stocktwits.com/symbol/ARKK">ARK Innovation ETF</a> (ARKK) and <a href="https://stocktwits.com/symbol/ARKG">ARK Genomic Revolution ETF</a> (ARKG), acquiring a total of more than 263,848 shares, according to Investing.com.</p><p>Meanwhile, the investment management firm’s largest trade of the day was the sale of 50,312 shares of Rocket Lab through the <a href="https://stocktwits.com/symbol/ARKQ">ARK Autonomous Technology &amp; Robotics ETF</a> (ARKQ), potentially totaling more than $4 million.</p><h2 class="st-heading-2">ARK’s Consistent Confidence In Intellia</h2><p>ARK’s latest investment in the gene-editing company reinforces its confidence in it as an innovative healthcare solutions company in the biotechnology sector, rather than a one-time bet. The firm has been steadily adding NTLA stock across its ETFs throughout 2026, with repeated purchases in January, February, March, and now April.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_04_28_at_10_27_21_AM_png_f5ec0a53bb.webp" alt="Screenshot 2026-04-28 at 10.27.21 AM.png" width="1854" height="1177"><figcaption>Source: ARK Investment Management</figcaption></figure><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_04_28_at_10_28_18_AM_png_1fb9515786.webp" alt="Screenshot 2026-04-28 at 10.28.18 AM.png" width="1855" height="1176"><figcaption>Source: ARK Investment Management</figcaption></figure><p>Intellia Therapeutics is a gene-editing company focused on developing CRISPR/Cas9-based therapeutics. On Monday, the company <a href="https://stocktwits.com/news-articles/markets/equity/ntla-stock-soars-intellia-positive-gene-therapy-trial/cZBNFouRe2C">reported positive Phase 3 trial results</a> for lonvoculin ziclumeran (lonvo-z) for the treatment of hereditary angioedema (HAE), a rare genetic condition.</p><p>The company has also said that it has initiated a rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for approval, and is preparing for a potential U.S. launch of lonvo-z in the first half of 2027.</p><h2 class="st-heading-2">Rocket Lab Offload</h2><p>Meanwhile, RKLB stock’s sale marks the firm’s second offload this month, even as the company’s shares have surged more than 262% in the last year, suggesting that the investment firm may be locking in gains after the rally.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_04_28_at_10_45_29_AM_png_645b3c168e.webp" alt="Screenshot 2026-04-28 at 10.45.29 AM.png" width="1818" height="1177"><figcaption>Source: ARK Investment Management</figcaption></figure><p>The space launch company specializes in small satellite launch services for commercial and government customers. Rocket Lab completed multiple Electron missions earlier this month, including its 8th launch of the year and 87th overall, reinforcing its position in the small-satellite launch market. The company also has a pipeline of upcoming missions backed by a growing backlog.</p><h2 class="st-heading-2">What Retail Traders Feel About NTLA, RKLB</h2><p>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NTLA">NTLA stock</a> was in the ‘extremely bullish’ territory amid ‘extremely high’ message volumes at the time of writing. For <a href="https://stocktwits.com/symbol/RKLB">RKLB stock</a>, retail sentiment was in the ‘bullish’ territory amid ‘normal’ message volumes.</p><p>Meanwhile, for the ARKK and ARKQ ETFs, retail sentiment was in the ‘bearish’ territory at the time of writing, while for the ARKG ETF, it was in the ‘neutral’ territory.</p><p>ARKK, ARKQ, and ARKG have gained more than 49%, 85%, and 33% in the last year, respectively.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

CEO & Chief Investment Officer of ARK Invest, Cathie Wood, addresses the audience at Altice Arena Centre Stage during the second day of the Web Summit 2022 in Lisbon. (Photo by Hugo Amaral/SOPA Images/LightRocket via Getty Images)

Cathie Wood's ARK Bets Bigger On This Biotech Play, Slashes Stake In This Space Stock 

ARK Investment Management bought shares worth more than $3.5 million of Intellia Therapeutics and sold shares of Rocket Lab worth more than $4 million on Monday. 

More NTLA, Less RKLB: Cathie Wood’s Latest ARK Trades Explained

Equity

Intellia Therapeutics Posts Phase 3 HAELO Win for lonvo-z, Begins Rolling FDA BLA Filing

Intellia Therapeutics (NASDAQ:NTLA) highlighted top-line results from its Phase III HAELO trial evaluating lonvo-z, an investigational in vivo CRISPR-based gene-editing therapy for hereditary angioedema (HAE), and provided an update on regulatory progress during a company conference call.

Company o...

Chardan Capital Forecasts Strong Price Appreciation for Intellia Therapeutics (NASDAQ:NTLA) Stock

Chardan Capital upped their target price on shares of Intellia Therapeutics from $27.00 to $30.00 and gave the stock a "buy" rating in a research report on Monday...

Robert W. Baird Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Robert W. Baird boosted their price target on Intellia Therapeutics from $7.00 to $13.00 and gave the stock a "neutral" rating in a report on Monday...

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - Should You Buy?

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - Here's What Happened...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NTLA News

NTLAIntellia Therapeutics Inc